(Q36188323)

12 August 2017

1 reference

title

Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature (English)

1 reference

12 August 2017

1

Nadine Shehab

1 reference

12 August 2017

Burgunda V Sweet

2

1 reference

12 August 2017

Norman D Hogikyan

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

25

1 reference

12 August 2017

issue

7

1 reference

12 August 2017

page(s)

977-989

1 reference

Quality of life issues in recurrent respiratory papillomatosis.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

The cost of juvenile-onset recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

National registry for juvenile-onset recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Risk factors for juvenile onset recurrent respiratory papillomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Laryngeal papillomavirus infection during clinical remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Latent papillomavirus and recurring genital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Pharmacotherapy of recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Recurrent respiratory papillomatosis with malignant transformation in a young adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Recurrent respiratory papillomatosis: Progression to invasion and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Treatment of recurrent respiratory papillomatosis in children with the microdebrider

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Microdebrider versus CO2 laser removal of recurrent respiratory papillomas: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Soft-tissue complications of laser surgery for recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Recurrent respiratory papillomatosis in the larynx: re-emergence of clinical disease following surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Acyclovir in the treatment of recurrent respiratory papillomatosis: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Cimetidine treatment for recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

American and Soviet teenagers' concerns about nuclear war and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Results of treatment with alpha-interferon in adult-onset laryngeal papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Variable light-dose effect on photodynamic therapy for laryngeal papillomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Isotretinoin therapy for recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Antivirals for the treatment of herpesvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Cidofovir in the therapy and short-term prophylaxis of poxvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Intralesional cidofovir for recurrent respiratory papillomatosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

A Scheduled Protocol for the Treatment of Juvenile Recurrent Respiratory Papillomatosis With Intralesional Cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Intralesional cidofovir and surgical excision for laryngeal papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Systemic cidofovir in papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Local and systemic effects of intralaryngeal injection of cidofovir in a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Alpha interferon augments cidofovir's antiviral and antiproliferative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

Treatment of recurrent respiratory papillomatosis with indole-3-carbinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.7.977

10.1592/PHCO.2005.25.7.977

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference